'Like Insider Trading' | GenomeWeb

One part of reading grant proposals Proflife Substance particularly enjoys is that it makes him think about his own work differently. But, he says, "herein lies a dilemma with all reviewing — determining where the line is between stimulating independent thought and leaning on someone else's ideas."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.